Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-27 @ 4:48 PM
Study NCT ID:
NCT05679050
Status:
UNKNOWN
Last Update Posted:
2023-01-10
First Post:
2022-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-15
First Submit QC Date:
None
Study First Post Date:
2023-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-08
Last Update Post Date:
2023-01-10
Last Update Post Date Type:
ACTUAL